Jonathan Sporn, MD
Co-Founder of Gilgamesh, the drug design company with several psychedelic research tracks, he has worked at Pfizer, Perception Neuroscience, Johnson & Johnson and Click Therapeutics.
Hello! This is my story.
Co-founded Synthesis in 2017. He is currently the executive director of an international team of 40 individuals who aim to make psychedelic tools accessible in a safe, legal, and modern context.
Nunc suscipit est fermentum, volutpat velit id, ultrices mauris. Nunc iaculis efficitur vehicula. Suspendisse malesuada urna et turpis luctus dapibus. Donec ex felis, auctor quis suscipit non, volutpat nec erat et turpis luctus.
MBA from Harvard Business School
University of Michigan
Section UX & UI design (2008)
Head of Industry
Self - employed
Professor and Consultant